Nashville-based artist CeCe Winans has been nominated for Grammy Awards 35 times. Sun. Feb. 1, 2026, she could take home her 18th Grammy Award. Her first live recording, "Believe For It," released in ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual property developed by Monsanto, the crop science company the German company ...

After missing the playoffs by betting on J.J. McCarthy in his first year as a starter, the Minnesota Vikings turn their attention to 2026 free agency as their 2025 campaign comes to a close. McCarthy, ...

CeCe Winans is receiving some backlash online after she posted a video of her sister, Debbie Winans, performing at this year’s Kennedy Center Honors. The gospel singer shared the video on her social ...

Thursday’s 119-96 loss to Houston was a third-straight blowout defeat for JJ Redick and the Lakers. Gary A. Vasquez / Imagn Images LOS ANGELES — When JJ Redick left behind his life talking about the ...

The next game from Left 4 Dead designer Mike Booth is putting a sci-fi spin on his last game's co-op action, based on a trailer Booth and producer JJ Abrams shared at The Game Awards 2025. The new ...

JJ Gabriel celebrates scoring against Peterborough in the FA Youth Cup Zohaib Alam - Manchester United via Getty Images Playing for the first time at Old Trafford, JJ Gabriel looked every bit at ease, ...

Vikings quarterback J.J. McCarthy should be ready to go for Sunday’s game against the Commanders. McCarthy cleared concussion protocol on Thursday, paving the way for his return to the starting lineup ...

Johnson & Johnson has teamed up with Naomi Watts to put a clearer focus on vision health, leveraging the actor’s star power to encourage women over 40 to make eye exams part of their self-care ...

The 2025–26 season has already exceeded expectations for JJ Redick and the Los Angeles Lakers. In his first season as head coach, Redick led the Lakers to a 50–32 record and the No. 3 seed in the ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while strengthening its prostate cancer franchise built on Erleada. At the center of the ...